OTC Aqueous-Based Oral Inhalation Drug Sterility Required Under Final Reg
This article was originally published in The Tan Sheet
Executive Summary
Aqueous-based OTC and Rx drugs for oral inhalation must be manufactured sterile under an FDA final rule published in the May 26 Federal Register.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning